24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz]
- RxCUI
- 810079
- RxNorm name
- 24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz]
- Display name
- 24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz]
- Full name
- 24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Toviaz | FESOTERODINE FUMARATE | Pfizer Laboratories Div Pfizer Inc | 5be745f0-8ae7-4c3c-9962-37d6263326f1 | 2026-04-07 | Warnings, Adverse reactions | 810079 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5be745f0-8ae7-4c3c-9962-37d6263326f1 | 24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz] | SBD | 33 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. TOVIAZ ® (fesoterodine fumarate) extended-release tablets, for oral use Initial U.S. Approval: 2008 | 20260407 |
| 5be745f0-8ae7-4c3c-9962-37d6263326f1 | Toviaz 8 MG 24HR Extended Release Oral Tablet | PSN | 33 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. TOVIAZ ® (fesoterodine fumarate) extended-release tablets, for oral use Initial U.S. Approval: 2008 | 20260407 |
| 5be745f0-8ae7-4c3c-9962-37d6263326f1 | Toviaz 8 MG 24 HR Extended Release Oral Tablet | SY | 33 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. TOVIAZ ® (fesoterodine fumarate) extended-release tablets, for oral use Initial U.S. Approval: 2008 | 20260407 |
| 5be745f0-8ae7-4c3c-9962-37d6263326f1 | 24 HR Toviaz 8 MG Extended Release Oral Tablet | SY | 33 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. TOVIAZ ® (fesoterodine fumarate) extended-release tablets, for oral use Initial U.S. Approval: 2008 | 20260407 |
| fead426f-b955-4b41-8553-f102d17afa3a | Toviaz 8 MG 24 HR Extended Release Oral Tablet | SY | 3 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. Toviaz ® (fesoterodine fumarate) For oral administration Initial U.S. Approval: 2008 | 20120406 |
| fead426f-b955-4b41-8553-f102d17afa3a | 24 HR Toviaz 8 MG Extended Release Oral Tablet | SY | 3 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. Toviaz ® (fesoterodine fumarate) For oral administration Initial U.S. Approval: 2008 | 20120406 |
| fead426f-b955-4b41-8553-f102d17afa3a | Toviaz 8 MG 24HR Extended Release Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. Toviaz ® (fesoterodine fumarate) For oral administration Initial U.S. Approval: 2008 | 20120406 |
| fead426f-b955-4b41-8553-f102d17afa3a | 24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz] | SBD | 3 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. Toviaz ® (fesoterodine fumarate) For oral administration Initial U.S. Approval: 2008 | 20120406 |
| e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26 | 24 HR Toviaz 8 MG Extended Release Oral Tablet | SY | 1 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. Toviaz ® (fesoterodine fumarate) For oral administration Initial U.S. Approval: 2008 | 20170315 |
| e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26 | Toviaz 8 MG 24 HR Extended Release Oral Tablet | SY | 1 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. Toviaz ® (fesoterodine fumarate) For oral administration Initial U.S. Approval: 2008 | 20170315 |
| e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26 | Toviaz 8 MG 24HR Extended Release Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. Toviaz ® (fesoterodine fumarate) For oral administration Initial U.S. Approval: 2008 | 20170315 |
| e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26 | 24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz] | SBD | 1 | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. Toviaz ® (fesoterodine fumarate) For oral administration Initial U.S. Approval: 2008 | 20170315 |